Breaking News Bar

Business News and Information

bluebird bio, up on first day of trading, plans late-stage study this year

A Cambridge, Mass. biotech, bluebird bio, has plans to begin a late-stage trial this year of a potential drug to treat a rare, inherited disorder that affects male children...
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear